4
Changes in Ownership
Tyra Biosciences, Inc. Filed Acc 0000950170-24-011880
Chief Operating Officer sold 90,806 shares at an average $16.63 ($1,509,925)
- Chief Operating Officer acquired 25,393 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bensen Daniel Chief Operating Officer | 2024-02-02 | Option exercise 10b5-1 | +25,393 | $0.61 | $15,490 | 553,374 | D |
| Bensen Daniel Chief Operating Officer | 2024-02-02 | Sale 10b5-1 | −73,093 | $16.31 | $1,191,898 | 480,281 | D |
| Bensen Daniel Chief Operating Officer | 2024-02-02 | Sale 10b5-1 | −2,300 | $17.04 | $39,199 | 477,981 | D |
| Bensen Daniel Chief Operating Officer | 2024-02-06 | Sale 10b5-1 | −15,413 | $18.09 | $278,827 | 462,568 | D |
| Derivatives | |||||||
| Bensen Daniel Chief Operating Officer | 2024-02-02 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,393 | 108,110 | D | ||
| Open-market sales · 90,806 sh · avg $16.63 · $1,509,925 | |||||||
Loading xslF345X05/ownership.xml…